• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何评估多重疾病:一项系统综述。

How to assess multimorbidity: a systematic review.

作者信息

Yao Li, Li Qiaoxing, Liu Yan, Li Qinqin, Wang Tingrui, Zhou Zihan, Yin Jiajia

机构信息

School of Management and Collaborative Innovation Laboratory of Digital Transformation and Governance, Guizhou University, Guiyang, Guizhou, China.

Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.

出版信息

Front Public Health. 2025 Mar 27;13:1525593. doi: 10.3389/fpubh.2025.1525593. eCollection 2025.

DOI:10.3389/fpubh.2025.1525593
PMID:40213437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11983592/
Abstract

OBJECTIVE

To comprehensively and systematically collect the methods used in the evaluation of patients with multiple chronic diseases both domestically and internationally, summarize and analyze the purpose, characteristics and validity of their initial development, and provide reference for health managers to choose appropriate evaluation methods for multiple chronic diseases.

METHODS

Analysis of the literature was based on searches conducted across eight electronic databases, including PubMed, EMBASE, Web of Science Core Collection, Scopus, Cochrane Library, CNKI, Wan Fang Database, and the Chinese Biomedical Literature Database (CBM). The initial search was completed on January 8, 2024, and the most recent update was conducted on December 10, 2024, with no restriction on the date of publication. The search process adhered to the 2020 PRISMA guidelines for systematic review.

RESULTS

54 literatures meeting the criteria were included, involving 54 evaluation methods of multiple chronic diseases. It can be divided into four categories: (1) assessment based on equal weight of disease count and disease severity; (2) based on physiological and psychological health status assessment; (3) evaluation based on drug use; (4) natural language processing evaluation system.

CONCLUSION

Attention should be paid to the assessment of patients with multiple chronic diseases, and standardized and unified assessment methods should be developed in the future to expand the coverage of diseases and deepen the depth of assessment, so as to provide more comprehensive and accurate health management for the growing number of patients with multiple chronic diseases.

WITHOUT PATIENT OR PUBLIC CONTRIBUTION

This systematic review is primarily based on the comprehensive analysis of published literature and did not involve new data collection or direct participation of patients, hence there was no direct contribution from patients or the public.

SYSTEMATIC REVIEW REGISTRATION

https://www.crd.york.ac.uk/prospero/, CRD42024530474.

摘要

目的

全面、系统地收集国内外用于评估慢性病患者的方法,总结并分析其最初开发的目的、特点和有效性,为卫生管理人员选择合适的慢性病评估方法提供参考。

方法

基于对八个电子数据库的检索进行文献分析,这些数据库包括PubMed、EMBASE、Web of Science核心合集、Scopus、Cochrane图书馆、中国知网、万方数据库和中国生物医学文献数据库(CBM)。初始检索于2024年1月8日完成,最近一次更新于2024年12月10日进行,对出版日期无限制。检索过程遵循2020年PRISMA系统评价指南。

结果

纳入54篇符合标准的文献,涉及54种慢性病评估方法。可分为四类:(1)基于疾病数量和疾病严重程度同等权重的评估;(2)基于生理和心理健康状况的评估;(3)基于药物使用的评估;(4)自然语言处理评估系统。

结论

应重视慢性病患者的评估,未来应制定标准化、统一的评估方法,扩大疾病覆盖范围,加深评估深度,以便为越来越多的慢性病患者提供更全面、准确的健康管理。

无患者或公众参与

本系统评价主要基于对已发表文献的综合分析,未涉及新的数据收集或患者的直接参与,因此患者或公众没有直接贡献。

系统评价注册

https://www.crd.york.ac.uk/prospero/,CRD42024530474。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d025/11983592/cf2e21244d5c/fpubh-13-1525593-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d025/11983592/796d23d7b7c6/fpubh-13-1525593-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d025/11983592/3927f2861ec9/fpubh-13-1525593-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d025/11983592/cf2e21244d5c/fpubh-13-1525593-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d025/11983592/796d23d7b7c6/fpubh-13-1525593-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d025/11983592/3927f2861ec9/fpubh-13-1525593-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d025/11983592/cf2e21244d5c/fpubh-13-1525593-g003.jpg

相似文献

1
How to assess multimorbidity: a systematic review.如何评估多重疾病:一项系统综述。
Front Public Health. 2025 Mar 27;13:1525593. doi: 10.3389/fpubh.2025.1525593. eCollection 2025.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
The Effectiveness of Collaborative Care Interventions for the Management of Patients With Multimorbidity: Protocol for a Systematic Review, Meta-Analysis, and Meta-Regression Analysis.协作护理干预对多重疾病患者管理的有效性:系统评价、荟萃分析和元回归分析方案
JMIR Res Protoc. 2024 Aug 8;13:e58296. doi: 10.2196/58296.
4
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
5
Risk prediction models for mortality in patients with multimorbidity: a systematic review and meta-analysis.多种合并症患者死亡率的风险预测模型:一项系统评价与荟萃分析
Front Public Health. 2025 Apr 2;13:1505541. doi: 10.3389/fpubh.2025.1505541. eCollection 2025.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.针对多病共存和多种药物治疗的老年人减药:TAILOR 证据综合。
Health Technol Assess. 2022 Jul;26(32):1-148. doi: 10.3310/AAFO2475.
8
Patient engagement in multimorbidity: a systematic review of patient-reported outcome measures.患者对多种疾病的参与度:对患者报告结局指标的系统评价
Front Psychol. 2024 Jul 17;15:1345117. doi: 10.3389/fpsyg.2024.1345117. eCollection 2024.
9
Effectiveness of Mobile Medical Apps in Ensuring Medication Safety Among Patients With Chronic Diseases: Systematic Review and Meta-analysis.移动医疗应用程序在确保慢性病患者用药安全方面的有效性:系统评价和荟萃分析。
JMIR Mhealth Uhealth. 2022 Nov 22;10(11):e39819. doi: 10.2196/39819.
10
Efficacy and Safety of Acupuncture for Post-COVID-19 Insomnia: Protocol for a Systematic Review and Meta-Analysis.针灸治疗新冠后失眠的疗效与安全性:系统评价与荟萃分析方案
JMIR Res Protoc. 2025 Mar 3;14:e69417. doi: 10.2196/69417.

本文引用的文献

1
Barriers and enablers for implementation of clinical practice guidelines in maternity and neonatal settings: A rapid review.妇产科和新生儿科临床实践指南实施的障碍与促进因素:一项快速综述
PLoS One. 2024 Dec 16;19(12):e0315588. doi: 10.1371/journal.pone.0315588. eCollection 2024.
2
Creating a Modified Version of the Cambridge Multimorbidity Score to Predict Mortality in People Older Than 16 Years: Model Development and Validation.创建改良版剑桥多病种评分以预测 16 岁以上人群的死亡率:模型的建立和验证。
J Med Internet Res. 2024 Aug 26;26:e56042. doi: 10.2196/56042.
3
Inequalities in Out-of-Pocket Health Expenditure Measured Using Financing Incidence Analysis (FIA): A Systematic Review.
使用筹资发生率分析(FIA)衡量的自费医疗支出不平等:一项系统评价。
Healthcare (Basel). 2024 May 20;12(10):1051. doi: 10.3390/healthcare12101051.
4
Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort.在英国生物样本库队列中实施和外部验证剑桥多种疾病评分。
BMC Med Res Methodol. 2024 Mar 20;24(1):71. doi: 10.1186/s12874-024-02175-9.
5
Associations of individual chronic diseases and multimorbidity with multidimensional frailty.个体慢性病和多种疾病与多维虚弱的关联。
Arch Gerontol Geriatr. 2024 Feb;117:105259. doi: 10.1016/j.archger.2023.105259. Epub 2023 Nov 4.
6
Comparing a new multimorbidity index with other multimorbidity measures for predicting disability trajectories.比较一种新的多病种指数与其他多病种测量方法,以预测残疾轨迹。
J Affect Disord. 2024 Feb 1;346:167-173. doi: 10.1016/j.jad.2023.11.014. Epub 2023 Nov 8.
7
Prevalence, patterns of multimorbidity and associations with health care utilization among middle-aged and older people in China.中国中老年人群的患病率、多病共存模式及其与医疗保健利用的关系。
BMC Public Health. 2023 Mar 21;23(1):537. doi: 10.1186/s12889-023-15412-5.
8
Measuring multimorbidity in research: Delphi consensus study.研究中多重疾病的测量:德尔菲共识研究。
BMJ Med. 2022 Jul 27;1(1):e000247. doi: 10.1136/bmjmed-2022-000247. eCollection 2022.
9
Costs of multimorbidity: a systematic review and meta-analyses.共病的成本:系统评价和荟萃分析。
BMC Med. 2022 Jul 19;20(1):234. doi: 10.1186/s12916-022-02427-9.
10
Improving multimorbidity measurement using individualized disease-specific quality of life impact assessments: predictive validity of a new comorbidity index.利用个体化疾病特异性生活质量影响评估改善多病共存测量:新合并症指数的预测效度。
Health Qual Life Outcomes. 2022 Jul 12;20(1):108. doi: 10.1186/s12955-022-02016-7.